Failure	failure	O	O
of	of	O	O
ancrod	ancrod	S_chemicals	O
in	in	O	O
the	the	O	O
treatment	treatment	O	O
of	of	O	O
heparin-induced	heparin-induced	O	O
arterial	arterial	O	O
thrombosis	thrombosis	O	S_disease
.	.	O	O

The	the	O	O
morbidity	morbidity	O	O
and	and	O	O
mortality	mortality	O	O
associated	associated	O	O
with	with	O	O
heparin-induced	heparin-induced	O	O
thrombosis	thrombosis	O	S_disease
remain	remain	O	O
high	high	O	O
despite	despite	O	O
numerous	numerous	O	O
empirical	empirical	O	O
therapies	therapies	O	O
.	.	O	O

Ancrod	ancrod	S_chemicals	O
has	has	O	O
been	been	O	O
used	used	O	O
successfully	successfully	O	O
for	for	O	O
prophylaxis	prophylaxis	O	O
against	against	O	O
development	development	O	O
of	of	O	O
thrombosis	thrombosis	O	S_disease
in	in	O	O
patients	patients	O	O
with	with	O	O
heparin	heparin	S_chemicals	O
induced	induced	O	O
platelet	platelet	B_chemicals	O
aggregation	aggregation	I_chemicals	O
who	who	O	O
require	require	O	O
brief	brief	O	O
reexposure	reexposure	O	O
to	to	O	O
heparin	heparin	S_chemicals	O
,	,	O	O
but	but	O	O
its	its	O	O
success	success	O	O
in	in	O	O
patients	patients	O	O
who	who	O	O
have	have	O	O
developed	developed	O	O
the	the	O	O
thrombosis	thrombosis	O	S_disease
syndrome	syndrome	O	S_disease
is	is	O	O
not	not	O	O
well	well	O	O
defined	defined	O	O
.	.	O	O

The	the	O	O
authors	authors	O	O
present	present	O	O
a	a	O	O
case	case	O	O
of	of	O	O
failure	failure	O	O
of	of	O	O
ancrod	ancrod	S_chemicals	O
treatment	treatment	O	O
in	in	O	O
a	a	O	O
patient	patient	O	O
with	with	O	O
heparin-induced	heparin-induced	O	O
thrombosis	thrombosis	O	S_disease
.	.	O	O

